APOB and atherosclerosis: Several studies have demonstrated effective early reduction of atherosclerosis in hyperlipidemic mouse models by inducing tolerance to modified lipids and peptides derived from apolipoprotein B (ApoB) 100, HSPs 60/65, and β2-glycoprotein [22], [23], [24], [25], [26], [27], [28].